Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
RUO
Fujirebio introduces blood-based RUO Alzheimer’s assays
By
LabPulse.com staff writers
The assays, which are for the quantitative measurement of E4 isoform of the apolipoprotein E (ApoE4) and all isoforms of the same protein (Pan-ApoE), respectively, extend Fujirebio’s current portfolio of RUO biomarker assays for the Lumipulse G system.
March 31, 2023
Illumina, Myriad Genetics provide U.S. access to HRD research test
By
LabPulse.com staff writers
The expanded partnership establishes a companion diagnostic (CDx) testing alliance for the pharmaceutical industry, which will enable more clinical research for gene-based, targeted therapies, the firms said.
March 6, 2023
Roche launches COVID-19 PCR test to detect fast-spreading XBB.1.5 Omicron subvariant
By
LabPulse.com staff writers
XBB.1.5 is prevalent in the U.S. and is quickly spreading to other countries. It is a subvariant of a SARS-CoV-2 variant called XBB. That lineage is a recombinant of two descendants of the BA.2 lineage, which began spiking early in 2022.
January 26, 2023
Grail launches methylation-based liquid biopsy solution for cancer research in a post-diagnosis setting
By
LabPulse.com staff writers
Potential research use cases include prognosis, minimal residual disease detection, and recurrence monitoring across different cancer types in research studies, the firm said.
January 10, 2023
Quanterix expands laboratory-developed-test menu with launch of neurofilament light chain test
By
LabPulse.com staff writers
The blood test expands access to an important brain health biomarker to advance research and clinical care, the firm said.
January 10, 2023
PCR-based life science tools top $5B, with digital PCR showing rapid growth: SDi report
By
Tanya Samazan
Among the PCR technologies for the life sciences laboratory tools industry, dPCR is the fastest growing, as evidenced by the recent market entry of large qPCR vendors.
December 6, 2022
Thermo Fisher Scientific introduces digital PCR liquid-biopsy assays for academic, clinical research
By
LabPulse.com staff writers
The assays are predesigned for research to identify genetic mutations, including challenging cancer hotspot mutations, and to help enable simplification of liquid biopsy workflows, Thermo Fisher said.
November 29, 2022
Biocare Medical acquires Empire Genomics to expand molecular biomarker portfolio
By
LabPulse.com staff writers
The acquisition of Empire Genomics will expand Biocare Medical’s molecular biomarker portfolio substantially.
November 22, 2022
Qiagen adds monkeypox test to automated PCR platform
By
LabPulse.com staff writers
Addressing a need to improve surveillance of monkeypox, Qiagen announced that it has launched a research-use-only monkeypox test strip capable of detecting both variants of the virus.
November 22, 2022
PerkinElmer launches adeno-associated virus vector detection kits for research
By
LabPulse.com staff writers
The new kits use bead-based luminescent amplification to provide researchers with an option that is less time-consuming than ELISA and other wash-based tests, as well as having a wide detection range and high throughput.
November 21, 2022
Bio-Rad Laboratories, NuProbe USA sign licensing agreement for digital PCR assays
By
LabPulse.com staff writers
The agreement allows NuProbe to license its allele enrichment technologies to Bio-Rad for the development of multiplexed digital PCR assays
November 8, 2022
Nucleai to present data on multiplex immunofluorescence analysis for colorectal cancer research
By
LabPulse.com staff writers
Nucleai will present data this week demonstrating the capability of multiplex immunofluorescence analysis to correlate spatial features with patient outcomes in colorectal cancer.
November 7, 2022
Page 1 of 3
Next Page
